GluMetrics

GluMetrics was a medical technology company focused on developing continuous glucose monitoring (CGM) systems specifically for the hospital environment, particularly intensive care units (ICUs). The company's flagship product, the GluCath Intravascular CGM System, utilized a proprietary optical fluorescence-based sensor integrated into a standard radial artery catheter. This technology was designed to provide real-time, accurate glucose readings to help clinicians manage glycemic control and prevent hypoglycemia in critically ill patients. By offering continuous data, the system aimed to replace intermittent manual blood sampling, which is often labor-intensive and prone to lag. Although the company successfully advanced its technology into clinical trials, it is no longer active in the market.